AstraZeneca (LSE:AZN)
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
About
Last updated 30-10-2020, 06:05:01pm GMTRelated Articles
-
Why I’m thinking of AstraZeneca as a great long-term buy
Motley Fool contributor Jay Yao writes why he's looking at FTSE 100 component AstraZeneca as a great long-term investment. Read More »
-
3 FTSE 100 stocks I’d buy to play India’s rise
Motley Fool contributor Jay Yao writes why he thinks these three FTSE 100 stocks have substantial upside given the development on India’s economy. Read More »
-
Why I’d buy these 2 UK dividend shares in an ISA today to make a passive income
These two UK dividend shares could offer a growing passive income, in my view. Buying them in an ISA today could be a shrewd... Read More »
-
Top British stocks for October 2020
We asked our freelance writers to share their top British stocks for October, including AstraZeneca, Pets At Home and Unilever. Read More »
-
Here are 3 safe FTSE 100 dividend hero stocks I’d buy and hold forever
FTSE 100 dividend hero stocks consistently make payouts. Here are three examples that I think are safe bets for income investors. Read More »
-
Why I think these 2 FTSE 100 stocks have huge upside
Motley Fool contractor Jay Yao writes how two FTSE 100 stocks, GlaxoSmithKline and AstraZeneca, could be great buys for long-term investors. Read More »
-
Is the AstraZeneca share price too high now? Here’s what you need to know
AstraZeneca shares have been rallying for a while. Aren't they too expensive right now? Anna Sokolidou thinks she knows the answer. Read More »
-
Are AstraZeneca shares worth buying?
AstraZeneca shares have a high price-to-earnings ratio, but I don't think you should let that put you off this FTSE 100 (INDEXFTSE:UKX) stock. Read More »
-
This biotech growth stock is hammering the AstraZeneca share price. Here’s what you need to know
The AstraZeneca share price is climbing. But this biotech firm is collaborating with the pharmaceuticals giant, and its shares have multi-bagged. Read More »
-
How I’d profit from AstraZeneca shares
AstraZeneca shares have almost doubled over the past five years. There could be more upside ahead. Read More »